893428-72-3

893428-72-3 structure
893428-72-3 structure
  • Name: Saracatinib difumarate
  • Chemical Name: (E)-but-2-enedioic acid,N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
  • CAS Number: 893428-72-3
  • Molecular Formula: C35H40ClN5O13
  • Molecular Weight: 774.171
  • Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK Src
  • Create Date: 2017-09-21 16:09:11
  • Modify Date: 2024-01-20 17:30:05
  • Saracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1].

Name (E)-but-2-enedioic acid,N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
Synonyms Saracatinib difumarate
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinamine (2E)-2-butenedioate (1:2)
UNII-8R1DYT4EAW
AZD-0530 difumarate
4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)
Description Saracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1].
Related Catalog
Target

IC50: 2.7 nM (Src), 30 nM (v-Abl), 66 nM (EGFR), 200 nM (c-Kit)[1]

References

[1]. Green TP, et al. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol, 2009, 3(3), 248-261.  

Molecular Formula C35H40ClN5O13
Molecular Weight 774.171
Exact Mass 773.231140
PSA 239.64000
LogP 3.31190